Cargando…

Patent foramen ovale closure vs. medical therapy alone after cryptogenic stroke in China: A cost-effectiveness analysis

BACKGROUND: In 2019, there were 28. 76 million patients with stroke in China, with ~25% of them suffering from cryptogenic stroke (CS). Patent foramen ovale (PFO) is related to CS, and PFO closure can reduce recurrent stroke. To date, no study has investigated the cost-effectiveness of PFO closure v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Na, Liu, Bo, Ma, Meijuan, Zhang, Xuejun, Zhang, Wei, Hou, Fangxia, Liu, Fuqiang, Yu, Xiangyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669480/ https://www.ncbi.nlm.nih.gov/pubmed/36407985 http://dx.doi.org/10.3389/fpubh.2022.1016854

Ejemplares similares

Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017)

Cost-effectiveness analysis of patent foramen ovale closure versus medical therapy alone after cryptogenic stroke
por: Shijoh, Yoko, et al.
Publicado: (2022)

Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives
por: Makhija, Rakhee R., et al.
Publicado: (2019)

Patent foramen ovale closure
por: Amin, Zahid
Publicado: (2010)

Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023)

Closure or medical therapy of patent foramen ovale in cryptogenic stroke: prospective case series
por: Poli, Sven, et al.
Publicado: (2021)

Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Experience in patent foramen ovale closure with the CERA Lifetech occluder in patients with cryptogenic stroke
por: Węglarz, Przemysław, et al.
Publicado: (2023)

Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population
por: Moon, Jeonggeun, et al.
Publicado: (2016)

Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline
por: Kuijpers, Ton, et al.
Publicado: (2018)

Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials
por: Ahmad, Yousif, et al.
Publicado: (2018)

Evaluation of Patent Foramen Ovale in Young Adults with Cryptogenic Stroke
por: Ali Ebrahimi, Hossein, et al.
Publicado: (2011)

Cryptogenic Stroke: To Close a Patent Foramen Ovale or Not to Close?
por: Kottoor, Santhosh J, et al.
Publicado: (2018)

Cryptogenic stroke and patent foramen ovale (abridged and translated version)
por: Diener, Hans-Christoph, et al.
Publicado: (2019)

Cryptogenic Ischemic Stroke in Migraine: Role of Patent Foramen Ovale
por: Gollion, Cédric, et al.
Publicado: (2022)

Odyssey of Patent Foramen Ovale: Closure in Cryptogenic Stroke: The Canary in the Coal Mine of Clinical Trials?
por: Vemulapalli, Sreekanth, et al.
Publicado: (2018)

Patent foramen ovale closure in non-lacunar cryptogenic ischemic stroke: where are we now?
por: ARBOIX, Adrià, et al.
Publicado: (2021)

Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?
por: Parrini, Iris, et al.
Publicado: (2020)

Patent Foramen Ovale Closure in 2019
por: Giblett, Joel P, et al.
Publicado: (2019)

Percutaneous Patent Foramen Ovale Closure in Patients with Cryptogenic Stroke or Transient Ischemic Attack: A Retrospective Study
por: Liu, Yuan, et al.
Publicado: (2022)

Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale
por: Spencer, Frederick A, et al.
Publicado: (2014)

Device closure for patent foramen ovale following cryptogenic stroke: a survey of current practice in the UK
por: Von Klemperer, Katherine, et al.
Publicado: (2017)

Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt
por: Dell’Angela, Luca, et al.
Publicado: (2023)

Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale
por: Tanislav, Christian, et al.
Publicado: (2010)

Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA
por: Mirzada, Naqibullah, et al.
Publicado: (2013)

Cryptogenic Stroke and Significance of the Patent Foramen Ovale: A Case Series
por: Pour-Ghaz, Issa, et al.
Publicado: (2018)

Characteristics and prognosis of patients with cryptogenic stroke and suggestive of patent foramen ovale
por: Choi, Jaehuk, et al.
Publicado: (2021)

Patent Foramen Ovale Closure: State of the Art
por: Giblett, Joel P, et al.
Publicado: (2020)

Intracardiac echocardiography in the diagnosis and closure of patent foramen ovale
por: HAN, Kang-Ning, et al.
Publicado: (2021)

Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
por: Mir, Hassan, et al.
Publicado: (2018)

Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: An update meta-analysis of randomized controlled trials
por: Ma, Yingxu, et al.
Publicado: (2018)

Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients
por: Han, Yangyang, et al.
Publicado: (2020)

Intermediate and Long-Term Results of Transcatheter Closure of Patent Foramen Ovale Using the Amplatzer Patent Foramen Ovale Occluder: One Case of Pulmonary Embolism Irrespective of Patent Foramen Ovale Closure
por: Yoon, Ju Hee, et al.
Publicado: (2011)

Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated systematic review and meta-analysis
por: Goel, Sunny, et al.
Publicado: (2019)

Correction: Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
Publicado: (2018)

Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention
por: Yuan, Kristy, et al.
Publicado: (2018)

Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
por: Sadrameli, Saeed S, et al.
Publicado: (2018)

Patent Foramen Ovale and Closure Technique with the Amplatzer Occluder
por: Meier, Bernhard
Publicado: (2014)

Percutaneous Patent Foramen Ovale Closure After Stroke
por: Lee, Oh-Hyun, et al.
Publicado: (2022)

Management of patent foramen ovale in patients with cryptogenic stroke: Is device closure superior to medical treatment? A brief review
por: Sidia, Besma, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_17meqsrfo92c2tkbt9q5v8e5m5